BIOGEN (DENMARK) A/S
CVR 21682977 · Public limited company (A/S) · Active · Low risk
BIOGEN (DENMARK) A/S is a Public limited company (A/S), founded on , based in Hellerup. The company is registered in the industry engroshandel med læge- og hospitalsartikler. Our model estimates a bankruptcy risk of 0.0% over the next 12 months, which is 0.0 times the average for Danish companies. 20 annual reports have been published, of which 2 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 151.9m and a net result of DKK 5.6m. CEO: Erik Magnus Bodin.
Bankruptcy risk for BIOGEN (DENMARK) A/S
0.0 × the average (1.41%) · higher risk than 15% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 21682977
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (27 years)
- Address
- Strandvejen 125
2900 Hellerup - Municipality
- København
- Industry
- Engroshandel med læge- og hospitalsartikler (464620)
Bankruptcies in the industry: Engroshandel med andre maskiner og andet udstyr - Share capital
- DKK 501k
- Employees
- 20 (2018)
- Auditor
- PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB
- Audit opted out
- No
Warning signs
| Annual reports filed late | 2 of 27 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 81.1% |
| Current ratio | 533% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 14 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 114 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | DKK 178.7m | DKK 234.0m | DKK 259.6m |
| Gross profit | DKK 34.1m | DKK 32.9m | DKK 44.2m |
| Net profit | DKK 5.6m | DKK 7.5m | DKK 8.3m |
| Equity | DKK 151.9m | DKK 146.3m | DKK 138.8m |
| Total assets | DKK 187.2m | DKK 191.1m | DKK 198.6m |
| Cash | DKK 134.9m | DKK 140.8m | – |
| Short-term debt | DKK 35.0m | DKK 44.4m | – |
| Tax owed | DKK 972k | DKK 890k | – |
| Avg. employees | 14 | 15 | – |
Latest annual report: Reporting class C, mellemstor virksomhed · auditor's statement: Revisionspåtegning · (venstre underskriver).
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 180 | ||
| 1 Jan 2024 – 31 Dec 2024 | 178 | ||
| 1 Jan 2023 – 31 Dec 2023 | 178 | ||
| 1 Jan 2022 – 31 Dec 2022 | 179 | ||
| 1 Jan 2021 – 31 Dec 2021 | 143 | ||
| 1 Jan 2020 – 31 Dec 2020 | 152 | ||
| 1 Jan 2019 – 31 Dec 2019 | 233 | Late | |
| 1 Jan 2018 – 31 Dec 2018 | 154 | ||
| 1 Jan 2017 – 31 Dec 2017 | 151 | ||
| 1 Jan 2016 – 31 Dec 2016 | 158 | ||
| 1 Jan 2015 – 31 Dec 2015 | 152 | ||
| 1 Jan 2014 – 31 Dec 2014 | 159 | ||
| 1 Jan 2013 – 31 Dec 2013 | 169 | ||
| 1 Jan 2012 – 31 Dec 2012 | 153 | ||
| 1 Jan 2011 – 31 Dec 2011 | 198 | Late | |
| 1 Jan 2010 – 31 Dec 2010 | 158 | ||
| 1 Jan 2009 – 31 Dec 2009 | 151 | ||
| 1 Jan 2008 – 31 Dec 2008 | 155 | ||
| 1 Jan 2007 – 31 Dec 2007 | 163 | ||
| 1 Jan 2006 – 31 Dec 2006 | 155 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Erik Magnus Bodin | Current | |
| CEO | James Henry Magnusen Kirkness | ||
| CEO | Karen Lykke Sørensen | ||
| CEO | Karl Anders Lundström | ||
| CEO | Peter Rützou-Hjelmkrone | ||
| CEO | Randolph Spicochi | ||
| CEO | Francis Marsland | ||
| CEO | Morten Lofthus Tangnes | ||
| Board | Allan Frank Fischer Petersen | Current | |
| Board | Neil Raymond Sisak | Current | |
| Board | Sergio Ferreira da Silva Teixeira | Current | |
| Board | Erik Magnus Bodin | Current | |
| Board | Tom Bork Petersen | ||
| Board | Peter Johan Lindborg | ||
| Board | James Henry Magnusen Kirkness | ||
| Board | Karen Lykke Sørensen | ||
| Board | Karl Anders Lundström | ||
| Board | Patrick Volkert Jozef Johannes Vink | ||
| Board | Jean-Yves Boursier | ||
| Board | Francis Paul Edward Marsland | ||
| Board | David Stephen Allsop | ||
| Board | Peter Lindborg | ||
| Board | Charlotte Leife | ||
| Board | Johny Humaloja | ||
| Board | David Gregory Davis | ||
| Board | Peter Rützou-Hjelmkrone | ||
| Board | Thomas Lackner | ||
| Board | Neil Raymond Sisak | ||
| Board | Thomas Francois Etienne Biet | ||
| Board | Janne Harder Holmelund | ||
| Board | Steven John Green | ||
| Board | Vesna Leskovsek Cizej | ||
| Board | Neil Raymond Sisak | ||
| Board | Ulf Johan Ström | ||
| Board | Tashia Susana Lentz | ||
| Board | Louise Hammerich | ||
| Board | Morten Lofthus Tangnes | ||
| Owner (100%) | Biogen Netherlands B.V. | Current | |
| Auditor | PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB | Current | |
| Auditor | PricewaterhouseCoopers, Statsautoriseret Revisionsinteressentskab | ||
| Auditor | PRICEWATERHOUSECOOPERS SERVICES STATSAUTORISERET REVISIONSAKTIESELSKAB | ||
| Founder | Biogen International B.V | Current |
The CEOs' other companies
Karen Lykke Sørensen – 13 other companies
- AFFITECH A/S Fusioneret
- CHEMOMETEC A/S Active
- DTU Science Park a/s Active
- EKSPORT KREDIT FINANSIERING A/S Opløst
- Enhance TopCo ApS Active
- KARPHI ApS Opløst
- Karphi ApS Active
- ORIFARM GROUP A/S Active
- PHILIPS DANMARK A/S Active
- PHILIPS HOME HEALTHCARE SOLUTIONS A/S Fusioneret
- SANOFI-SYNTHÉLABO A/S Fusioneret
- Sanofi A/S Active
- Signify Denmark A/S Active
Peter Rützou-Hjelmkrone – 3 other companies
Address history (4 moves)
| Strandvejen 125, 2900 Hellerup | |
| Stationsparken 37, 3., 2600 Glostrup | |
| Ørestads Boulevard 67, 1., 2300 København S | |
| Lyngbyvej 28, 2100 København Ø | |
| c/o Bech-Bruun & Trolle. advokatfirma, Nørre Farimagsgade 3, 1364 København K |
Former names
| BIOGEN (DENMARK) A/S | – now |
| BIOGEN IDEC (DENMARK) A/S | – |
| BIOGEN (DENMARK) A/S | – |
Employees per year
Other companies at the same address
- E & S - Consult IVS Bankrupt
- Redline Media Group ApS Bankrupt
- VIA Telegroup Danmark ApS Bankrupt
- AL Copenhagen A/S Active
- AP Management ApS Active
- AarhusGeoSoftware ApS Opløst
- Administrationsselskabet i "Buen" ApS Active
- Andersen & Friends Holding ApS Active
- BAKKEDAL INVEST ApS Opløst
- BESTYRELSESPOSTEN ApS Opløst
- Biofuel Technology Holding ApS Active
- Borderless Denmark Holdings ApS Active
- CAPNORDIC HOLDING ApS Active
- CKIT HOLDING ApS Active
- CKIT Software ApS Opløst
- COHAMI HOLDING ApS Opløst
- CREDITSAFE DENMARK ApS Active
- Clarify Commerce ApS Active
- Classic Maritime ApS Active
- CoreWeave SVL01 ApS Active
- Crone Burmeister Adv. ApS Active
- CyberOne ApS Active
- Dansk Demetra ApS Active
- Davy DebtCo ApS Active
- Davy PledgeCo ApS Active
Similar companies in København
- Kaliber ApS Valby
- Reinsberg Group Nordic ApS København K
- ResQ NXT ApS København K
- Steripolar ApS København K
- NB DENTAL APS Valby
- MiniMed Denmark ApS Nordhavn
- MILA International Europe A/S København V
- ATECH HEALTH ApS København K
- Vitestro Denmark ApS København Ø
- CosmoLight ApS København SV
- Rheia Medical ApS København N
- Copenhagen Medical Cryo ApS København Ø
Questions and answers about BIOGEN (DENMARK) A/S
Has BIOGEN (DENMARK) A/S gone bankrupt?
No, BIOGEN (DENMARK) A/S is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of BIOGEN (DENMARK) A/S?
Our model estimates a bankruptcy risk of 0.0% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.
Who is the CEO of BIOGEN (DENMARK) A/S?
Erik Magnus Bodin is the CEO of BIOGEN (DENMARK) A/S.
Who is the auditor of BIOGEN (DENMARK) A/S?
BIOGEN (DENMARK) A/S most recently used PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB.
When was BIOGEN (DENMARK) A/S founded?
BIOGEN (DENMARK) A/S was founded on 19 April 1999.
What is the equity of BIOGEN (DENMARK) A/S?
Equity was DKK 151.9m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.